| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef4f341fe4f2caf061611a818576e40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate |
2010-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_238ccc271faa3fc9285bcb2f0ce438e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f151947d5721447b4088393988c448 |
| publicationDate |
2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2012005901-A |
| titleOfInvention |
LIQUID PHARMACEUTICAL COMPOSITIONS. |
| abstract |
Aqueous liquid pharmaceutical composition comprising a) almotriptan and b) at least one compound selected from i) 1'-methyl-5 - ((pyrrolidin-1-ylsulfonyl) methyl) spiro [indoline-3,3'-p irrolidin] -2 -ol, and ii) 3- (2- (dimethylamino) ethyl) -5 - ((pyrrolidin-1-ylsulfonyl) methyl) -1H-indole-2-ol. |
| priorityDate |
2009-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |